Timothy Goodnow
Vermögen: 6 Mio $ am 31.07.2026
Vermögen: 6 Mio $ am 31.07.2026
Timothy T.
Goodnow is President, Chief Executive Officer & Director at Senseonics Holdings, Inc. since 2015.
Dr. Goodnow is President & Chief Executive Officer at Senseonics, Inc. since 2011.
Former positions include Principal at Baxter Healthcare Corp., Vice President-Research & Development at TheraSense, Inc., Principal at Verax Biomedical, Inc., Vice President-Technical Operations at Abbott Diabetes Care, Inc. from 2000 to 2011, and Principal at Dade Behring, Inc. Education includes undergraduate and doctorate degrees from the University of Miami.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.06.2026 | 1’143’748 ( 2.19% ) | 6 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SENSEONICS HOLDINGS, INC. | Vorstandsvorsitzender | 01.12.2015 |
Senseonics, Inc.
Senseonics, Inc. Electronic ComponentsElectronic Technology Develops transformative glucose monitoring products | Vorstandsvorsitzender | 01.03.2011 |
| Unternehmen | Position | Ende |
|---|---|---|
Abbott Diabetes Care, Inc.
Abbott Diabetes Care, Inc. Medical SpecialtiesHealth Technology Manufactures glucose monitoring equipments | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2011 |
TheraSense, Inc.
TheraSense, Inc. Medical SpecialtiesHealth Technology Manufactures and develops blood glucose self-monitoring systems | Technik-/Wissenschafts-/F&E-Leiter | 06.04.2004 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Corporate Officer/Principal | - |
Dade Behring, Inc.
Dade Behring, Inc. Medical SpecialtiesHealth Technology Manufactures medical diagnostic equipment | Corporate Officer/Principal | - |
Verax Biomedical, Inc.
Verax Biomedical, Inc. Medical SpecialtiesHealth Technology Develops rapid tests for detecting bacterial contaminants in blood cells and tissues | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
TheraSense, Inc.
TheraSense, Inc. Medical SpecialtiesHealth Technology Manufactures and develops blood glucose self-monitoring systems | Health Technology |
Verax Biomedical, Inc.
Verax Biomedical, Inc. Medical SpecialtiesHealth Technology Develops rapid tests for detecting bacterial contaminants in blood cells and tissues | Health Technology |
University of Miami
University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Senseonics, Inc.
Senseonics, Inc. Electronic ComponentsElectronic Technology Develops transformative glucose monitoring products | Electronic Technology |
Abbott Diabetes Care, Inc.
Abbott Diabetes Care, Inc. Medical SpecialtiesHealth Technology Manufactures glucose monitoring equipments | Health Technology |
Dade Behring, Inc.
Dade Behring, Inc. Medical SpecialtiesHealth Technology Manufactures medical diagnostic equipment | Health Technology |
Senseonics Holdings, Inc.
Senseonics Holdings, Inc. Electronic ComponentsElectronic Technology Develops transformative glucose monitoring products | Electronic Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen